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Abstract
Background: The Global Alliance for Chronic Diseases comprises the majority of the world’s public research
funding agencies. It is focussed on implementation research to tackle the burden of chronic diseases in
low- and middle-income countries and amongst vulnerable populations in high-income countries. In its
inaugural research call, 15 projects were funded, focussing on lowering blood pressure-related disease
burden. In this study, we describe a reflexive mapping exercise to identify the behaviour change strategies
undertaken in each of these projects.
Methods: Using the Behaviour Change Wheel framework, each team rated the capability, opportunity and
motivation of the various actors who were integral to each project (e.g. community members, non-physician
health workers and doctors in projects focussed on service delivery). Teams then mapped the interventions
they were implementing and determined the principal policy categories in which those interventions were
operating. Guidance was provided on the use of Behaviour Change Wheel to support consistency in
responses across teams. Ratings were iteratively discussed and refined at several group meetings.
Results: There was marked variation in the perceived capabilities, opportunities and motivation of the various
actors who were being targeted for behaviour change strategies. Despite this variation, there was a high
degree of synergy in interventions functions with most teams utilising complex interventions involving
education, training, enablement, environmental restructuring and persuasion oriented strategies. Similar policy
categories were also targeted across teams particularly in the areas of guidelines, communication/marketing
and service provision with few teams focussing on fiscal measures, regulation and legislation.
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Conclusions: The large variation in preparedness to change behaviour amongst the principal actors across these
projects suggests that the interventions themselves will be variably taken up, despite the similarity in approaches taken.
The findings highlight the importance of contextual factors in driving success and failure of research programmes.
Forthcoming outcome and process evaluations from each project will build on this exploratory work and provide a
greater understanding of factors that might influence scale-up of intervention strategies.
Keywords: Implementation science, Hypertension, Behaviour change theory, Collaborative research, Low- and
middle-income countries
Background
Elevated blood pressure (BP) is the greatest modifiable risk
factor for global burden of disease, responsible for approxi-
mately 9.4 million deaths annually and about 7 % of
disability-adjusted life years (DALYs) [1]. Importantly, the
global burden attributable to elevated BP has increased
markedly over the last 20 years, from approximately 137
million DALYs in 1990 to 174 million DALYs in 2010,
emphasising the epidemiological transition that has oc-
curred during this time period [1]. In addition, the greatest
proportion of this burden now rests with low- and middle-
income countries (LMICs), with over 80 % of deaths from
elevated BP occurring in these regions [2]. The global cost
of elevated BP is estimated to reach nearly US$1 trillion
over the next decade [3]. Unless adequately controlled, BP-
related disease will continue to be responsible for substan-
tial health and economic burden worldwide.
The Global Alliance for Chronic Diseases (GACD) was
founded in 2009 by five of the world’s largest national
government health research funding agencies. It has
since grown to comprise ten national funding agencies
that together contribute 80 % of the world’s publicly
funded research [4]. Its overall goal is to tackle the bur-
den of chronic diseases in LMICs and amongst vulner-
able populations in high-income countries. It seeks to
achieve this by systematically building the implementa-
tion research evidence base for sound policymaking
through targeted research calls that are coordinated
across all participating funding agencies.
For its first joint funding initiative, the GACD focussed
on the prevention, management and control of elevated
BP. The central aims of the research programme are to (1)
develop a better understanding of critical barriers and facil-
itators at local and national levels that affect BP control
and to consider how implementation challenges can be
overcome, (2) to understand how innovations for BP
control can be introduced and scaled-up across a range of
settings and (3) to identify what health system elements
must be strengthened to improve BP control whilst
reducing disparities across population sub-groups. The
programme includes 15 projects spanning 15 LMICs and
Aboriginal communities in Canada, with approximately
US$23 million committed over 5 years. Protocols for
several of the funded projects have been published [5–22],
and project synopses are available on the GACD website
(www.gacd.org) [23].
In this paper, we outline a mapping exercise that was
undertaken collaboratively by the 15 research teams.
Specific aims are to (1) identify in each project the target
behaviour change and the principal actors who are cen-
tral to achieving change, (2) to use a behaviour change
model to determine each team’s perception of the influ-
ences on these actors to change behaviour and (3) to map
the intervention functions used by each team to promote
behaviour change amongst these actors and to determine
the principal policy categories in which those interven-
tions are operating. This mapping work was undertaken
in the early stages of the 5-year GACD Hypertension
Research Programme and serves as a benchmark upon
which to gauge progress following the implementation of
the component studies.
Methods
Participants
A GACD research programme committee comprising at
least one high-income country and one LMIC represen-
tative from each of the 15 teams was formed in 2012. At
the committee’s first meeting in late 2012, research team
representatives commenced collaborative work to better
understand the local contexts in which we were working
and to determine the degree of alignment of our various
studies and interventions. Although there is a high
degree of variation in the settings, there were many
similarities in approach. All funded teams are seeking to
change prevailing behaviours at the level of individuals
(e.g. community members, health service attendees and
health care providers), organisations (health care services,
educational institutions, food providers) and systems
(local and large scale policy initiatives). A working group
comprising representatives from most of the 15 research
teams and the GACD funding agencies was consequently
formed to undertake a mapping exercise to better under-
stand and synthesise the behaviour change dynamics in
these projects.
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Behaviour change framework
The working group drew on Michie and colleagues’
Behaviour Change Wheel framework to systematically
map the respective behaviour change “targets” of each
project (Fig. 1) [24]. This framework comprises a be-
haviour system at the hub involving three essential
conditions: capability, opportunity and motivation (the
COM-B model). Encircling this hub are nine interven-
tion functions, aimed at addressing deficits in one or more
of these conditions. A larger wheel surrounds these inter-
vention functions and comprises seven policy categories.
These policy categories are broader population-level strat-
egies that could enable those interventions to occur. The
intervention and policy codes within this framework are
provided in Table 1.
Survey procedure
A survey tool was developed in which we asked research
teams to conduct the following activities. First, teams
outlined in one sentence what they considered to be
the principal behaviour change target for their project.
Second, they used the Behaviour Change Wheel to identify
the current capabilities, opportunities and motivations
of the principal “actors” that must be engaged in order to
achieve those targets. A simple, 3-point rating was provided
to gauge the strengths of each actor within each COM-B
component (e.g. community health worker capability to
improve BP control in the clinic could be rated as low,
medium or high). Although there are sub-components to
the COM-B model (e.g. physical and social opportunity),
we did not provide ratings at this level in order to minimise
complexity for many research teams who were new to
this model. Third, each team mapped their proposed
interventions against each of the Behaviour Change
Wheel intervention functions. Teams were encouraged
to classify all of their intervention strategies that they
were deploying regardless of whether they were dir-
ectly related to the target behaviour change. Fourth,
each team identified the principal policy categories in
which those interventions were either actively influen-
cing or being influenced. Researchers were provided
with the definitions for each of the intervention and
policy categories as part of the survey tool (Table 1).
These definitions and guidance on how to categorise
interventions followed the principles in the paper by
Michie and colleagues [24].
To assist teams in completing the survey tool, several
strategies were undertaken. A working group, compris-
ing several researchers and representatives from the
GACD funding agencies, was convened to guide devel-
opment of the survey tool. One research team who had
previously used the Behaviour Change Wheel theory
completed the survey tool for their project and provided
this as an exemplar for the other teams. The principal
investigator from this team also conducted teleconfer-
ences with each of the research teams to guide them
through use of the tool and to ensure there was a con-
sistent understanding of the survey terms. Teams were
Fig. 1 The Behaviour Change Wheel [24]. Notes: At the centre of the wheel are the COM-B model components. Capability refers to an individual’s
physical and psychological capacity (e.g. comprehension, literacy, reasoning) to engage in the activity concerned. It includes having the necessary
knowledge and skills to enact the target behaviour. Motivation refers to brain processes that energise and direct behaviour. Includes automatic
processes characterised by habit, emotions and impulses as well as reflective processes involving analytical decision making, making plans and
evaluating them. Opportunity refers to the factors that lie outside the individual that make behaviour change possible or prompt it. Can be
physical opportunities afforded by the environment in which people live or social opportunity which is affected by the cultural milieu in which
we think about things, words we use and concepts that make up our language [24]
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encouraged to complete the tool as a group activity, to
closely engage local stakeholders and to draw on existing
research conducted in the regions they were working.
Because such activities are inherently reductive in
nature, we also encouraged teams to provide a more
detailed narrative description of key contextual factors
that influenced their ratings. Table 2 outlines how the
process was conducted in one of the projects.
Analysis
Upon completion of the first survey draft, the prelimin-
ary results were presented at the second annual steering
committee meeting in late 2013 which all research teams
attended. This provided an opportunity for further
engagement in refining the responses made in the tool.
Further, because projects were at different stages when
the initial mapping work was done, several teams
adapted their responses on the basis of exploratory
research they had conducted in the early stages of their
projects. In this way each team’s survey response was
iteratively revised over a 12-month period. The findings
were again presented at the 2014 annual steering com-
mittee meeting. General consensus on the key messages
was obtained, and the working group drafted the find-
ings for publication.
Table 1 Intervention functions and policy categories in the
Behaviour Change Wheel
Interventions
Education Increasing knowledge or understanding
Persuasion Using communication to induce positive or
negative feelings or stimulate action
Incentivisation Creating expectation of reward
Enablement Increasing means/reducing barriers to increase
capability or opportunity beyond education,
training and environmental restructuring
respectively
Training Imparting skills
Coercion Creating expectation of punishment or cost
Restriction Using rules to reduce the opportunity to engage
in the target behaviour(or increase the
opportunity to engage in competing behaviours)
Environmental
restructuring
Changing the physical and social context
Modelling Providing an example for people to aspire
to or imitate
Policies
Communication/
marketing
Using print, electronic, telephonic or broadcast
media
Guidelines Creating documents that recommend or
mandate practice
Fiscal measures Using the tax system to reduce or increase the
financial cost
Regulation Establishing rules or principles of behaviour or
practice
Legislation Making or changing laws
Environmental/social
planning
Designing and/or controlling the physical or
social environment
Service provision Delivering a service
Table 2 SMARThealth India- Project 7 (IND 7)
Project overview
SMARThealth India uses mobile technologies to provide village-based,
non-physician health workers with personalised clinical decision support
to guide cardiovascular disease (CVD) risk assessment and management.
The system is being tested in rural villages in Andhra Pradesh, India. It is
integrated with government primary health care centres. Individuals
identified at high CVD risk are referred to the treating doctor for
ongoing management and follow-up. The doctor also has access to the
decision support tools and patients are provided with interactive voice
prompts to support ongoing care and follow-up. The system is being
tested in a stepped-wedge cluster randomised controlled trial involving
18 primary health care centres, 54 villages and around 15,000 individuals
at high CVD risk. The primary outcome is improvements in the
proportion of people at high CVD risk who are achieving national
guidelines blood pressure targets.
Previous research conducted to inform this work
The research team has been working in this region for the past decade.
Previous studies had been conducted documenting the rise in blood
pressure related disease burden in the region and gaps in access to
recommended treatments had been quantified [34]. An intervention trial
had also been conducted which found that non-physician health
workers could perform routine CVD risk assessments to the level of a
physician using a simple paper-based algorithm chart [35].
Pilot study
Building on this work, a prototype tablet based decision support 'app'
was developed and trialed for use by 11 non-physician health workers
and three government doctors for around 200 patients. The COM-B
model was used to guide the evaluation [22]. The qualitative
component identified three inter-related interview themes: (1) the
decision support technology had potential to change prevailing health
care models, (2) shifting tasks traditionally performed by a doctor to the
community health worker was the central driver of change, and (3)
despite high acceptability by end users, actual healthcare transformation
was substantially limited by system-level barriers such as patient access
to doctors and medicines.
Completion of the survey tool
On the basis of the above information the SMARThealth research team
met via teleconference to complete the survey. The target behaviour
change is to improve blood pressure control amongst people at high
CVD risk. A consensus approach was taken to determine the ratings and
this was informed by the recently completed pilot evaluation. Doctor
capability was rated high, however, motivation and opportunity were
rated low. The pilot evaluation found that working conditions, salary
and competing priorities were all factors that limited doctors from
improving blood pressure control in the target population. For health
workers capability was low as most health workers had no previous
experience in conducting CVD risk assessments, however, motivation
was assessed as high as previous research demonstrated high levels of
interest in expanding current roles to include chronic disease screening
and prevention. Current opportunities, however, to do this are low as
there are few chronic disease training programs for this workforce.
Community capability and opportunity were rated low as previous
studies have demonstrated large health literacy gaps and major
shortfalls in people's ability to access health care. Motivation to engage
in the primary health care sector was rated medium as community
members interviewed during the pilot had varying confidence in the
ability of this sector to meet their healthcare needs.
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Table 3 Funded research projects, behaviour change targets and planned interventions. Restrictions; Education; Persuasion; Incentivisation; Coercion; Training; Enablement;
Modelling; Environmental restructuring. Guidelines; Environment/social planning; Communication/marketing; Legislation; Service provision; Regulation; Fiscal measures. “Partially”
encompasses categories where some elements of a particular intervention characteristic are present, but it was not the dominant feature
Project code
(team no)
Funding agency Target countries/regions Target behaviour change Intervention Intervention function Policy categories
Interventions involving mobile health technologies
IND 7 NHMRC India-Andhra Pradesh Improved BP control
amongst people at
high cardiovascular
disease risk
A primary health care mHealth
system for use by NPHWs and
government primary health care
centre doctors
• Education • Guidelines
• Persuasion • Communication/
marketing (partially)
• Incentivisation • Service provision
(partially)
• Training
• Enablement
• Environmental
restructuring
TZA 3/CAN 3 CIHR, GCC, IDRC,
and CSN
Tanzania/Canada Improved HT control
through improved
screening, lifestyle
changes and
medication use
Primary health care intervention
involving linkage of primary health
care workers and patients via a
short message system (SMS)
mHealth system, combined with
contextually and culturally specific
training programmes for health
care workers in the two settings
• Education • Guidelines
• Training • Environment/social
planning
• Persuasion (partially) • Communication/
marketing
• Incentivisation (partially) • Legislation (partially)
• Enablement (partially) • Service provision
(partially)
• Environmental
restructuring (partially)
• Regulation (partially)
COL/MYS 2 CIHR, GCC, IDRC,
and CSN
Colombia/Malaysia Improved BP control
through improved
screening, lifestyle
changes and medication use
Primary health care programme
for cardiovascular disease risk
assessment, treatment and
control involving: (1) simplified
algorithms implemented by
NPHWs and supported by
e-health technologies; (2)
initiation of evidence based medications;
(3) treatment supports to optimise
long-term medication and lifestyle
adherence; and (4) macro-policy
initiatives to support sustainability
• Education • Guidelines
• Persuasion • Environment/social
planning
• Training
• Enablement • Communication/
marketing
• Service provision
• Legislation (partially)
KEN 13 NIH (NHLBI) Kenya Linking and retaining
hypertensive individuals
to hypertensive care
A behavioural communication
strategy and use of mHealth tools
to improve linkage into health
care and optimal BP control
• Education • Guidelines
• Persuasion • Communication/
marketing
• Training • Service provision
• Enablement
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Results
The 15 research projects, their proposed behaviour
change targets and a brief summary of the interventions
proposed are outlined in Table 3. Two teams (Tanzania/
Canada and South Africa/Uganda) completed separate
templates for each region they were working in due to a
high degree of variation in the principal actors operating
in each region of the same project. Projects broadly
aligned into two topic areas—health care delivery inter-
ventions (the majority) and salt reduction/substitute
interventions. For the healthcare delivery interventions,
a range of multifaceted strategies are being tested to im-
prove screening, detection, management and follow-up
of individuals with elevated BP. These include task-
shifting of doctor responsibilities to non-physician health
workers (NPHWs) (nurses, community health workers
and peer lay workers) and integrating primary health
care clinics with existing models of care for other
diseases (e.g. HIV clinics). Several project teams are also
incorporating an “mHealth” component which com-
prises multi-dimensional elements including provider,
patient and administrative applications that are access-
ible via a mobile device for the provision and receipt of
healthcare. The remaining projects are targeting salt re-
duction at both organisational levels (schools and com-
munities) and at policy levels. Different strategies being
implemented include salt substitutes, peer-led school
education programmes, policy interventions around salt
levels in foods and meals and community campaigns.
Figure 2 outlines the results of the behaviour change
mapping exercise using radial charts to preserve specifi-
city for each team’s ratings. A smaller “web” indicates
low ratings for the COM-B components across all pro-
jects whilst a larger web indicates higher ratings. For
most projects, there were three principal actors (com-
munity, NPHWs and doctors), and we focussed on these
groups in the results. In some projects, other actors were
also identified, particularly for the salt reduction projects
where community organisations, food outlets and schools
were the main focus of activity rather than health services.
Ratings for these groups and the changes made by groups
over time to their ratings are outlined in Additional file 1:
Figure S1. A detailed summary of each team’s contextual
information for their survey responses is also available in
Additional files 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15,
16, 17 and 18.
Most of the radial charts in Fig. 2 are highly irregular
in shape, indicating wide variability in ratings across pro-
jects and no clear overall pattern. The one exception to
this was that almost all projects rated doctor capability
to engage in the target behaviour as medium to high,
reflecting higher levels of training, knowledge and skills
in the topic area. NPHW capability was variable with
eight projects assigning a medium rating, three projects
a high rating and three projects a low rating. All teams
rated community capability as low to medium. There
was a high degree of variability in motivation ratings
across all regions, interventions and actors, although
generally, community motivation tended to be rated low
to medium. Opportunity for behaviour change tended to
be rated low to medium for the majority of projects for
all actors with one noteworthy exception in Argentina in
which opportunity was rated high for all actors. Apart
from the mhealth projects having similar motivation rat-
ings across actors, there were few other clear patterns of
COM-B ratings by intervention type (salt, mHealth and
innovative delivery strategies) (Fig. 2).
Figure 3 outlines the number of projects that are tar-
geting particular intervention functions. All projects are
engaging in multiple intervention functions (median = 6,
range 2–8) with education, training, enablement, envir-
onmental restructuring and persuasion being the most
common strategies deployed. These were particular
strong elements in the projects involving task-sharing
with non-physician, frontline health workers. Several
projects are focussing on environmental restructuring
either through different health care delivery models or
through changing access to salt in the food supply.
Fewer projects are using incentivisation, restrictions and
modelling. No projects are using coercion strategies.
Figure 4 shows the policy categories in which the pro-
posed interventions are interacting. Again most projects
are operating across multiple policy categories (median
number of categories = 3, range 1–6) with guidelines,
service provision and communication/marketing being the
most common. Few projects are engaged in more struc-
tural policy categories such as legislation, regulation and
social planning. No projects are employing fiscal measures.
Discussion
This exploratory study of a global implementation
research programme used behaviour change theory to
map activities for 15 research projects operating in 15
countries. In doing so, we were able to synthesise the
approaches being taken to tackle BP-related disease in a
wide range of settings. The principal finding from the
mapping activity was the marked variation in the per-
ceived capabilities, opportunities and motivations of the
various actors we aim to influence through these projects.
This suggests that the ability to change behaviour differs
greatly across regions and between actors. Although there
was a great variation in behaviour change ratings, there
was a high degree of synergy in the types of projects that
have been funded through this programme. Most projects
are multifaceted, focusing on education, enablement
and training strategies to promote behaviour change
and most projects are drawing on “softer” policy levers
such as guidelines, communication/marketing and service
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Table 3 Funded research projects, behaviour change targets and planned interventions. Restrictions; Education; Persuasion; Incentivisation; Coercion; Training; Enablement;
Modelling; Environmental restructuring. Guidelines; Environment/social planning; Communication/marketing; Legislation; Service provision; Regulation; Fiscal measures. “Partially”
encompasses categories where some elements of a particular intervention characteristic are present, but it was not the dominant feature (Continued)
• Environmental
restructuring
• Incentivisation (partially)
ARG 14 NIH (NHLBI) Argentina Improved BP control
amongst hypertensive
subjects via improved
medication adherence,
home monitoring and a
lifestyle modification
programme
Primary health care intervention
comprising provider education,
a home-based lifestyle and BP
monitoring consultation for
patients and their families
delivered by NPHWs and a
mHealth intervention
• Education • Guidelines
• Persuasion • Service provision
• Incentivisation
• Training
• Enablement
• Environmental
restructuring
Innovative health care delivery strategies
NGA 15 NIH (NINDS) Nigeria Empowering patients
who have had a stroke
to improve their adherence
to medicines and
recommended health
care visits
A new model of care comprising
a stroke patient report card, SMS
messages from care providers,
and in-clinic educational
video sessions
• Education • Guidelines
• Persuasion • Communication/
marketing
ZAF 1 CIHR, GCC, IDRC,
and CSN
South Africa—Western Cape/
Uganda
Improved control of BP
amongst people with HIV
N/A (Observational study) N/A N/A
UGA 1
ZAF 5 MRC South Africa-Mpumalanga Changing clinic systems
and behaviour of health
professionals in the clinic
Primary health care intervention
in which a clinic based lay health
worker will support outreach
teams to improve access and
quality of care for patients with
elevated BP
• Education • Service provision
• Training
• Enablement
• Environmental
restructuring
• Persuasion (partially)
IND 6 NHMRC India-3 rural regions Improved control of BP
amongst rural-dwelling
people with hypertension
Peer group based support
incorporating monitoring and
education, and a non-physician
health care facilitator. Health
system and workforce strengthening.
• Education • Guidelines
• Persuasion • Environment/social
planning
• Incentivisation • Communication/
marketing
• Training • Service provision
• Enablement • Guidelines (partially)
• Modelling
• Environmental
• restructuring
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Table 3 Funded research projects, behaviour change targets and planned interventions. Restrictions; Education; Persuasion; Incentivisation; Coercion; Training; Enablement;
Modelling; Environmental restructuring. Guidelines; Environment/social planning; Communication/marketing; Legislation; Service provision; Regulation; Fiscal measures. “Partially”
encompasses categories where some elements of a particular intervention characteristic are present, but it was not the dominant feature (Continued)
IND 8 NHMRC India/Sri Lanka-fixed dose combin-
ation BP-lowering pill
Improve prescriber and
patient uptake of
BP-lowering medication
Outpatient clinic trial of a low dose
3-in-1 low cost BP-lowering pill
compared with usual treatment
regimes. 700 patients will be
randomised to treatment with a
triple low dose BP-lowering
medication or routine management
of hypertension according to
usual practice. Primary outcome
is proportion reaching target
at 6 months.
• Enablement
• Environmental
restructuring
GHA 12 NIH (NHLBI) Ghana Improved BP control
amongst patients with
uncontrolled hypertension
who receive care in
community-based primary
care practices
Comparative effectiveness study
of an World Health Organisation
package of interventions involving
task-shifting to Community Health
Nurses versus provision of health
insurance coverage
• Education • Guidelines
• Persuasion • Environment/social
planning
• Incentivisation • Communication/
marketing
• Training • Service provision
• Enablement • Regulation
• Modelling
• Environmental
restructuring
Salt reduction strategies
IND 9 NHMRC India—national Reduction in dietary intake
of salt and reduction of salt
levels in foods and meals
through the development
of local and national policies
for salt reduction
N/A (Observational study) N/A • Guidelines
• Communication/
marketing
FJI/ WSM 10 NHMRC Pacific Islands Reduce salt use Multi-pronged cross sectoral
programmes targeting
community-wide salt reduction
• Education • Guidelines
• Training • Communication/
marketing
• Environmental
restructuring
• Regulation
CHN 4 MRC China Lowered salt intake in
children and their families
A school-based education
programme to reduce salt
intake in children and
their families
• Restrictions • Guidelines
• Education • Environment/social
planning
• Persuasion • Communication
/marketing
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Table 3 Funded research projects, behaviour change targets and planned interventions. Restrictions; Education; Persuasion; Incentivisation; Coercion; Training; Enablement;
Modelling; Environmental restructuring. Guidelines; Environment/social planning; Communication/marketing; Legislation; Service provision; Regulation; Fiscal measures. “Partially”
encompasses categories where some elements of a particular intervention characteristic are present, but it was not the dominant feature (Continued)
• Incentivisation • Service provision
(partially)
• Training
• Enablement
• Modelling
• Environmental
restructuring
PER 11 NIH (NHLBI) Peru Replacing common salt for
a potassium-enriched salt
(substitute); incorporating
and consuming the salt
substitute in the usual diet
A community-wide salt substitution
programme involving community,
community kitchens, and food
suppliers
• Education • Communication/
marketing
• Persuasion
• Incentivisation
• Training
• Enablement
• Modelling
• Environmental
restructuring
• Restrictions (partially)
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provision rather than restrictive policies such as regula-
tion, fiscal measures and legislation. This possibly reflects
the nature of the initial GACD funding request for pro-
posals, the funding amounts available and the duration of
the grants.
The main strength of this study is the collaborative na-
ture of the work involving all 15 teams funded by the
GACD. By drawing on the collective experiences of re-
searchers working in diverse regions, we were able to cap-
italise on research that had been conducted prior to these
Fig. 2 Capability, opportunity and motivation ratings of community members, non-physician health workers and doctors in 15 research projects. +
not working with this particular target group. * rating not provided. Notes: (1) Research teams are ordered around the plot by their strategy
according to Table 2 and then alphabetically. (2) Each team provided ratings on a 3-point scale (low (inner ring), medium (middle ring) and high
(outer ring)) for each of the “actors” with whom they were targeting their interventions. This was done for each of the COM-B components
(capability, opportunity and motivation). The more peripheral the location, the higher the rating. (3) Teams provided additional explanatory text
providing contextual information for how they arrived at their ratings. Please see the supplemental online files. (4) Several projects are targeting other
“actors”, and these are not included in these figures (e.g. for the India triple pill project, ratings are left blank for NPHWs as this project is not engaging
with these groups; for the Peru salt project, ratings are left blank for doctors and NPHWs as this project is mainly engaging with the community,
community kitchens and retail food outlets.) Please refer to the individual project templates in the supplemental online files to view their ratings for
these other actors
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specific GACD-funded projects. Although there are exam-
ples of theme-specific bilateral funding agency research
programmes [25–27], the GACD is a multilateral funding
initiative focussed on implementation science principles.
There are few examples of such global implementation
programmes [28], and therefore, this programme provides
an opportunity to synthesise common elements across re-
search projects. This behaviour change mapping activity
facilitated early cross-fertilisation of ideas between teams.
New working groups focussed on other topic areas are
now developing, and it is expected the group discussions
will further promote the development of peer-to-peer
networks and synthesis of activities that are common to
multiple groups and regions. Another feature of the
GACD is close engagement between researchers and the
funding agencies. The activities of the Hypertension Re-
search Programme are already being used to inform future
research programme funding calls.
Although the iterative and self-reflexive nature of the
work was generally considered to be a positive experience
by the participating researchers, it also raises the possibility
of potential limitations. First, the use of a uniform mapping
template required study teams to work within the con-
straints of the Behaviour Change Wheel framework. Given
most teams did not use the framework in the original de-
signing of their interventions, in effect we were “retro-fit-
ting” it to provide an overall classification structure for the
15 projects. There is the potential that such an exercise re-
sulted in teams forcing “square pegs into round holes” with
a resultant lack of attention to individual project specifics.
Although the framework fitted particularly well for health
care delivery interventions, it was less easy to apply in the
more policy-oriented interventions (such as salt reduction)
and non-intervention-focussed observational studies.
Second, although there were specific efforts undertaken to
ensure consistent understanding of the Behaviour Change
Wheel framework, it is possible that teams interpreted
definitions of the categories differently. Further, it must be
emphasised that we based the study on researcher percep-
tions which introduces a somewhat subjective element to
the exercise. This is mitigated, in part, by the fact that the
research teams have conducted substantial prior empirical
work to help inform these ratings (e.g. see Table 2). Third,
the reductive nature of the exercise prevented us from pro-
viding a more expansive justification for particular ratings
for the COM-B model components although teams did
provide additional data on the contextual factors that influ-
enced particular choices. For example, it is possible that
rating individual actors was too simplistic, neglecting the
importance of interaction between actors (e.g. teamwork in
the health centre) and the dynamic interplay between
various actor groups in influencing the likelihood of an
intervention being implemented.
Although we expected similar actors to exhibit similar
COM-B ratings across projects, the high degree of vari-
ability we observed suggests that the actors themselves
and the local contexts in which they operate may be
different. Further, the interventions themselves, although
similar in nature are complex, and the extent to
which they are tailored to the regions in which they are
working are likely to be a critical driver of outcomes. We
postulate that these different actor-context-intervention
constellations will be key drivers of why similar interven-
tions may produce different outcomes and why similar
actors may differentially adopt those interventions. When
taken as a whole, the GACD research programme,
therefore, has potential to contribute important in-
sights into the factors that influence particular imple-
mentation strategies.
The different approaches highlight the importance of
detailed process evaluations to better understand the
reach, fidelity of adoption and maintenance of interven-
tions over time rather than simply focussing on whether
the interventions “worked” or not. The UK Medical
Research Council has recently published a process
Fig. 3 Intervention functions for the 15 research projects using the
Behaviour Change Wheel framework
Fig. 4 Policy categories for the 15 research projects using the
Behaviour Change Wheel framework
Peiris et al. Implementation Science  (2015) 10:158 Page 11 of 15
evaluation framework for complex interventions which
companions its 2008 complex interventions guidance
[29, 30]. It draws substantially from realist evaluation, a
“mid-range” theory, which is increasingly being used to
understand the interaction between context, mechanism
and outcome for particular programmes [31]. Rather
than viewing interventions as “magic bullets that will hit
their target”, realist evaluation seeks to answer the ques-
tion “what works, for whom, and in what circumstances?”
[32, 33]. The GACD research programme provides oppor-
tunities for research teams to address these questions
collectively. A crucial initial step in conducting a realist
evaluation is to make explicit the underlying assumptions
about how an intervention is meant to work and what
impact it is expected to have. The next stage is to review,
with the empirical data arising from the projects, whether
these theories are supported, contradicted or need modifi-
cation in some way. This process will enable us to expose
the generative mechanisms of the intervention and its
interaction with particular contextual features (e.g. roles
and relationships of personnel at health services, ser-
vice infrastructure, who pays for healthcare, access to
essential medicines etc.). Several GACD teams have
integrated process evaluations as part of their overall
project aims, and some are explicitly using realist
evaluation frameworks.
Conclusions
In this paper, we have collectively used a theoretical
framework, the Behaviour Change Wheel, to make expli-
cit our hypothesised intervention effects. Subsequent
work will be conducted toward the end of the
programme when we will re-visit the mapping exercise
undertaken here and use the empirical data from each
project to derive a more nuanced analysis of what actu-
ally happened. There are important practical policy im-
plications arising from these activities. By making
explicit the types of context-mechanism-outcome con-
figurations that are associated with success and failure,
policy makers will be better informed on what and how
to scale-up in non-research settings. Such activities may
also yield important insights into potential policy
changes that might need to be enacted for such inter-
ventions to be successful at scale (e.g. role expansion for
NPHWs). Finally, the outcomes of such activities are in-
structive for funding agencies and will help inform
how global research programmes can be developed into
“implementation laboratories”, thereby, delivering new
knowledge that extends beyond the individual research
projects that they fund.
Availability of supporting data
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